Avanos Medical Inc. (AVNS)
15.10
0.05 (0.33%)
At close: Mar 03, 2025, 3:59 PM
15.13
0.20%
After-hours: Mar 03, 2025, 04:55 PM EST
Avanos Medical Cash Flow Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -392.1M | -61.8M | 50.5M | 5.2M | -27.2M | -45.9M | 57.5M | 79.3M | 39.8M | -426.3M | 27.1M | 154.6M | 152.6M | 142.4M |
| Depreciation & Amortization | 45.5M | 46.1M | 47.7M | 38.3M | 42.9M | 36.9M | 33.5M | 59.5M | 65.2M | 65.4M | 85.4M | 69.2M | 57.6M | 51.1M |
| Stock-Based Compensation | 13.8M | 15.8M | 15.9M | 13.2M | 12.1M | 10.5M | 10.5M | 12.6M | 14.8M | 14.1M | 7.9M | 6M | 5.3M | 2.6M |
| Other Working Capital | -4M | -47.3M | -4.1M | 31.5M | -72.9M | 46.1M | -112.3M | 9M | 35.7M | -20.5M | -3.9M | -21.8M | -9.7M | -27.6M |
| Other Non-Cash Items | 398.5M | 50.3M | 1.1M | 8M | 11.6M | -9.9M | -107.4M | 3.3M | -11.1M | 453.2M | 49.7M | 6.8M | -10.9M | 8.3M |
| Deferred Income Tax | n/a | n/a | n/a | -3.4M | 25.9M | -6.5M | 3.7M | -6.2M | -11.5M | 8.2M | -35M | -900K | -11.6M | 3.5M |
| Change in Working Capital | 35M | -18M | -24.3M | 26M | -67.8M | -59.6M | -143.4M | -4.3M | 91.6M | -17M | 12.8M | -11.9M | 9.6M | -68.3M |
| Operating Cash Flow | 100.7M | 32.4M | 90.9M | 87.3M | -2.5M | -74.5M | -145.6M | 144.2M | 188.8M | 97.6M | 147.9M | 223.8M | 202.6M | 139.6M |
| Capital Expenditures | -17.8M | -17.8M | -19.3M | -21M | -20.2M | -50.6M | -49.1M | -43.2M | -29.1M | -70.4M | -78.5M | -49M | -40.8M | -39.7M |
| Acquisitions | n/a | 39.4M | -116.1M | n/a | -4M | -57.5M | 688.6M | 100K | -175M | 7.8M | n/a | -2.2M | n/a | -3.7M |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.2M | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 49M | n/a | n/a |
| Other Investing Acitivies | -9.7M | n/a | -116.1M | n/a | -4M | -57.5M | 754.3M | 100K | 3.2M | 7.8M | 7.8M | -46.5M | 500K | 3.9M |
| Investing Cash Flow | -27.5M | 21.6M | -135.4M | -21M | -24.2M | -108.1M | 639.5M | -43.1M | -200.9M | -62.6M | -70.7M | -50.9M | -40.3M | -39.5M |
| Debt Repayment | -33.6M | -64.7M | 103.4M | -50M | -69.8M | -200K | -339M | n/a | -900K | -51M | 624.2M | -63.9M | -24.1M | 11.8M |
| Common Stock Repurchased | -12.8M | -19.1M | -45.5M | -11.5M | -900K | -3.6M | -900K | -2.5M | -900K | -1M | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -680M | n/a | n/a | n/a |
| Other Financial Acitivies | -2.7M | -10.4M | -1.2M | 6.2M | 700K | 5.3M | 15.5M | 4.7M | 400K | 1.4M | -595M | -116.1M | -109.8M | -126.9M |
| Financial Cash Flow | -49.1M | -94.2M | 56.7M | -55.3M | -70M | 1.5M | -324.4M | 2.2M | -1.4M | -50.6M | 29.2M | -180M | -133.9M | -115.1M |
| Net Cash Flow | 20M | -40M | 9.2M | 7M | -93.8M | -179.2M | 164.8M | 106M | -15.8M | -19.5M | 104.9M | -3.8M | 27.8M | -14.2M |
| Free Cash Flow | 82.9M | 14.6M | 71.6M | 66.3M | -22.7M | -125.1M | -194.7M | 101M | 159.7M | 27.2M | 69.4M | 174.8M | 161.8M | 99.9M |